查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1645725

全球药用塞剂市场按类型、基础、配方类型、治疗用途、填充类别、年龄层、分销管道和最终用户划分 - 机会分析和行业预测，2024 年至 2035 年

Pharmaceutical Suppositories Market By Type, By Base, By Prescription Type, By Therapeutic Application, By Fill Volume Categories, By Age Group, By Distribution Channel, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 423 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年药用塞剂市场价值估计为 16.6809 亿美元，预计到 2035 年将达到 32.3932 亿美元，2024 年至 2035 年的复合年增长率为 5.7%。

医药供应市场-IMG1

药用塞剂是固态剂型，用于插入体腔，在体腔中溶解或熔化以释放活性成分。它们通常使用可可脂、甘油明胶和聚乙二醇 (PEG) 等基质配製而成，以提供稳定性并允许控製药物释放。製造过程包括熔化基质、将其与活性药物成分 (API) 和任何所需的赋形剂混合，并将混合物形成所需的形状。冷却后栓剂凝固，包装备用。塞剂旨在透过黏膜吸收来输送药物。

药用塞剂市场因多种关键因素而不断成长。老年人常难以吞嚥锭剂，需要局部给药。此外，胃肠道疾病和某些癌症等慢性疾病的发生率不断上升，对塞剂所能提供的标靶治疗的需求也日益增长。药物传递技术的进一步进步扩大了可透过塞剂给药的药物范围和有效性。例如，美国国家医学图书馆于 2023 年发表的一项研究表明，与儿科人群中的口服给药相比，透过直肠途径给药的阿奇霉素栓剂的生物有效性显着提高。此外，政府提倡早期诊断的措施和製药公司提高公众对塞剂益处的认识的努力也进一步推动了市场的成长。

然而，也存在一些阻碍市场扩张的挑战。有限的药物相容性仍然是一个问题，因为由于溶解度问题，并非所有药物都能透过塞剂持续或有效地输送。此外，复杂的製造流程需要专门的设备，这增加了生产成本并限制了製造商的数量。这些因素限制了市场准入、增加了成本并影响了整体承受能力。儘管有这些挑战，但由于塞剂在药物传递方面的独特优势，其需求仍在持续上升。

药用塞剂市场分为类型、基础、配方类型、治疗用途、填充类别、年龄层、成分类型、分销管道和地区。根据类型，市场分为直肠塞剂、阴道塞剂和尿道塞剂。依基质不同，可分为脂肪族基质、水溶性基质、乳化基质。水溶性基质又分为甘油明胶基质、皂甘油栓剂基质、聚乙二醇基质等。乳化基进一步分为Witepsol、Massaesterium和Massapol。依剂型类型，栓剂分为OTC塞剂和处方塞剂。依治疗用途，分为止痛药/抗发炎药、止吐药、泻药、荷尔蒙疗法、抗霉菌/抗菌药等。依填充量类别分为小填充量、中填充量、大填充量。依年龄组别分为儿童版和成人版。根据成分类型，它们被分为原料药和辅料。依销售管道可分为医院药局、零售药局、网路销售。根据最终用户，市场分为医院/诊所、居家医疗和其他。根据地区，市场分析涵盖北美、欧洲、亚太、拉丁美洲、中东和非洲。

相关人员的主要利益

  • 该报告定量分析了 2023 年至 2035 年药用塞剂市场分析的市场细分、当前趋势、估计和动态，并确定了药用塞剂市场的突出机会。
  • 它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。
  • 波特五力分析强调了买家和供应商的力量，帮助相关人员做出以利润为导向的商业决策，并加强供应商-买家网路。
  • 药用塞剂市场细分的详细分析有助于确定市场机会。
  • 每个地区的主要国家都根据收益贡献进行划分。
  • 市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。
  • 报告包括区域和全球药用塞剂市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化（可能需要支付额外费用和製定时间表）

  • 根据客户兴趣加入公司简介
  • 扩展公司简介列表
  • 历史市场资料
  • 导入/汇出分析/资料

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 关键影响因素
    • 重大投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 急性和慢性疾病盛行率上升
      • 老年人口不断增加
      • 加强对塞剂使用的认识与教育力道
    • 限制因素
      • 製造药用塞剂的复杂性
      • 塞剂的储存和稳定性问题
    • 机会
      • 製剂技术的进步

第四章 药用塞剂市场（按类型）

  • 概述
  • 直肠栓剂
  • 阴道栓剂

第 5 章 药用塞剂市场（依基础）

  • 概述
  • 脂肪基
  • 水溶性基质
    • 水溶性药用塞剂市场（按类型划分）
  • 乳化基料
    • 乳化型药用塞剂市场（按类型划分）

6. 药用塞剂市场（依剂型划分）

  • 概述
  • 非处方药
  • 处方栓剂

第七章 药用塞剂市场（依治疗用途）

  • 概述
  • 止痛药和消炎药
  • 止吐药
  • 泻药
  • 荷尔蒙疗法
  • 抗真菌药物和抗菌药物
  • 其他的

8. 药用塞剂市场（依灌装量分类）

  • 概述
  • 小体积包装
  • 中等容量灌装机
  • 大容量包装材料

第 9 章 药用塞剂市场（依年龄层）

  • 概述
  • 儿科
  • 对于成年人

第 10 章 药用塞剂市场（依分销管道）

  • 概述
  • 医院药房
  • 药局和零售药局
  • 线上提供者

第 11 章 药用塞剂市场（依最终用户）

  • 概述
  • 医院和诊所
  • 居家医疗
  • 其他的

第十二章 药用塞剂市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他的
  • 拉丁美洲
    • 拉丁美洲
    • 中东和非洲

第十三章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第十四章 公司简介

  • Intas Pharmaceuticals Ltd.
  • Pfizer Inc.
  • Church & Dwight Co. Inc.
  • Zydus Lifesciences Limited
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bliss GVS Pharma Ltd
  • Bausch Health Companies Inc.
  • Cosette Pharmaceuticals, Inc.
简介目录
Product Code: A12350

The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.

Pharmaceutical Suppositories Market - IMG1

Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.

The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies' efforts to raise public awareness of suppository benefits, further support market growth.

However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.

The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data

Key Market Segments

By Prescription Type

  • OTC
  • Prescribed Suppositories

By Therapeutic Application

  • Analgesics and Anti-Inflammatory Drugs
  • Antiemetics
  • Laxatives
  • Hormonal Therapies
  • Antifungals and Antibacterials
  • Others

By Fill Volume Categories

  • Small Fill Volumes
  • Medium Fill Volumes
  • Large Fill Volumes

By Type

  • Rectal Suppositories
  • Vaginal Suppositories

By Age Group

  • Pediatric Use
  • Adult Use

By Base

  • Fatty Bases
  • Water Miscible Base
    • Type
    • Glycero Gelatin Base
    • Soap Glycerin Suppositories
    • Polyethylene Glycol Bases
  • Emulsifying Bases
    • Type
    • Witepsol
    • Massa Esterium
    • Massuppol

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By End User

  • Hospitals and Clinics
  • Home Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East And Africa

Key Market Players:

    • Bausch Health Companies Inc.
    • Bayer AG
    • Bliss GVS Pharma Ltd
    • Church & Dwight Co. Inc.
    • Cosette Pharmaceuticals, Inc.
    • Intas Pharmaceuticals Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Zydus Lifesciences Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of acute & chronic disorders
      • 3.4.1.2. Increase in the geriatric population
      • 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
    • 3.4.2. Restraints
      • 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
      • 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in formulation technology

CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rectal Suppositories
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Vaginal Suppositories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Fatty Bases
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Water Miscible Base
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
  • 5.4. Emulsifying Bases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
    • 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type

CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. OTC
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Prescribed Suppositories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Analgesics and Anti-Inflammatory Drugs
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Antiemetics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Laxatives
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Hormonal Therapies
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country
  • 7.6. Antifungals and Antibacterials
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by region
    • 7.6.3. Market share analysis by country
  • 7.7. Others
    • 7.7.1. Key market trends, growth factors and opportunities
    • 7.7.2. Market size and forecast, by region
    • 7.7.3. Market share analysis by country

CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Small Fill Volumes
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Medium Fill Volumes
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Large Fill Volumes
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP

  • 9.1. Overview
    • 9.1.1. Market size and forecast
  • 9.2. Pediatric Use
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by region
    • 9.2.3. Market share analysis by country
  • 9.3. Adult Use
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by region
    • 9.3.3. Market share analysis by country

CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL

  • 10.1. Overview
    • 10.1.1. Market size and forecast
  • 10.2. Hospital Pharmacies
    • 10.2.1. Key market trends, growth factors and opportunities
    • 10.2.2. Market size and forecast, by region
    • 10.2.3. Market share analysis by country
  • 10.3. Drug Stores and Retail Pharmacies
    • 10.3.1. Key market trends, growth factors and opportunities
    • 10.3.2. Market size and forecast, by region
    • 10.3.3. Market share analysis by country
  • 10.4. Online Providers
    • 10.4.1. Key market trends, growth factors and opportunities
    • 10.4.2. Market size and forecast, by region
    • 10.4.3. Market share analysis by country

CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER

  • 11.1. Overview
    • 11.1.1. Market size and forecast
  • 11.2. Hospitals and Clinics
    • 11.2.1. Key market trends, growth factors and opportunities
    • 11.2.2. Market size and forecast, by region
    • 11.2.3. Market share analysis by country
  • 11.3. Home Care
    • 11.3.1. Key market trends, growth factors and opportunities
    • 11.3.2. Market size and forecast, by region
    • 11.3.3. Market share analysis by country
  • 11.4. Others
    • 11.4.1. Key market trends, growth factors and opportunities
    • 11.4.2. Market size and forecast, by region
    • 11.4.3. Market share analysis by country

CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION

  • 12.1. Overview
    • 12.1.1. Market size and forecast By Region
  • 12.2. North America
    • 12.2.1. Key market trends, growth factors and opportunities
    • 12.2.2. Market size and forecast, by Type
    • 12.2.3. Market size and forecast, by Base
    • 12.2.4. Market size and forecast, by Prescription Type
    • 12.2.5. Market size and forecast, by Therapeutic Application
    • 12.2.6. Market size and forecast, by Fill Volume Categories
    • 12.2.7. Market size and forecast, by Age Group
    • 12.2.8. Market size and forecast, by Distribution Channel
    • 12.2.9. Market size and forecast, by End User
    • 12.2.10. Market size and forecast, by country
      • 12.2.10.1. U.S.
      • 12.2.10.1.1. Market size and forecast, by Type
      • 12.2.10.1.2. Market size and forecast, by Base
      • 12.2.10.1.3. Market size and forecast, by Prescription Type
      • 12.2.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.1.6. Market size and forecast, by Age Group
      • 12.2.10.1.7. Market size and forecast, by Distribution Channel
      • 12.2.10.1.8. Market size and forecast, by End User
      • 12.2.10.2. Canada
      • 12.2.10.2.1. Market size and forecast, by Type
      • 12.2.10.2.2. Market size and forecast, by Base
      • 12.2.10.2.3. Market size and forecast, by Prescription Type
      • 12.2.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.2.6. Market size and forecast, by Age Group
      • 12.2.10.2.7. Market size and forecast, by Distribution Channel
      • 12.2.10.2.8. Market size and forecast, by End User
      • 12.2.10.3. Mexico
      • 12.2.10.3.1. Market size and forecast, by Type
      • 12.2.10.3.2. Market size and forecast, by Base
      • 12.2.10.3.3. Market size and forecast, by Prescription Type
      • 12.2.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.3.6. Market size and forecast, by Age Group
      • 12.2.10.3.7. Market size and forecast, by Distribution Channel
      • 12.2.10.3.8. Market size and forecast, by End User
  • 12.3. Europe
    • 12.3.1. Key market trends, growth factors and opportunities
    • 12.3.2. Market size and forecast, by Type
    • 12.3.3. Market size and forecast, by Base
    • 12.3.4. Market size and forecast, by Prescription Type
    • 12.3.5. Market size and forecast, by Therapeutic Application
    • 12.3.6. Market size and forecast, by Fill Volume Categories
    • 12.3.7. Market size and forecast, by Age Group
    • 12.3.8. Market size and forecast, by Distribution Channel
    • 12.3.9. Market size and forecast, by End User
    • 12.3.10. Market size and forecast, by country
      • 12.3.10.1. Germany
      • 12.3.10.1.1. Market size and forecast, by Type
      • 12.3.10.1.2. Market size and forecast, by Base
      • 12.3.10.1.3. Market size and forecast, by Prescription Type
      • 12.3.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.1.6. Market size and forecast, by Age Group
      • 12.3.10.1.7. Market size and forecast, by Distribution Channel
      • 12.3.10.1.8. Market size and forecast, by End User
      • 12.3.10.2. France
      • 12.3.10.2.1. Market size and forecast, by Type
      • 12.3.10.2.2. Market size and forecast, by Base
      • 12.3.10.2.3. Market size and forecast, by Prescription Type
      • 12.3.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.2.6. Market size and forecast, by Age Group
      • 12.3.10.2.7. Market size and forecast, by Distribution Channel
      • 12.3.10.2.8. Market size and forecast, by End User
      • 12.3.10.3. UK
      • 12.3.10.3.1. Market size and forecast, by Type
      • 12.3.10.3.2. Market size and forecast, by Base
      • 12.3.10.3.3. Market size and forecast, by Prescription Type
      • 12.3.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.3.6. Market size and forecast, by Age Group
      • 12.3.10.3.7. Market size and forecast, by Distribution Channel
      • 12.3.10.3.8. Market size and forecast, by End User
      • 12.3.10.4. Rest of Europe
      • 12.3.10.4.1. Market size and forecast, by Type
      • 12.3.10.4.2. Market size and forecast, by Base
      • 12.3.10.4.3. Market size and forecast, by Prescription Type
      • 12.3.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.4.6. Market size and forecast, by Age Group
      • 12.3.10.4.7. Market size and forecast, by Distribution Channel
      • 12.3.10.4.8. Market size and forecast, by End User
  • 12.4. Asia-Pacific
    • 12.4.1. Key market trends, growth factors and opportunities
    • 12.4.2. Market size and forecast, by Type
    • 12.4.3. Market size and forecast, by Base
    • 12.4.4. Market size and forecast, by Prescription Type
    • 12.4.5. Market size and forecast, by Therapeutic Application
    • 12.4.6. Market size and forecast, by Fill Volume Categories
    • 12.4.7. Market size and forecast, by Age Group
    • 12.4.8. Market size and forecast, by Distribution Channel
    • 12.4.9. Market size and forecast, by End User
    • 12.4.10. Market size and forecast, by country
      • 12.4.10.1. Japan
      • 12.4.10.1.1. Market size and forecast, by Type
      • 12.4.10.1.2. Market size and forecast, by Base
      • 12.4.10.1.3. Market size and forecast, by Prescription Type
      • 12.4.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.1.6. Market size and forecast, by Age Group
      • 12.4.10.1.7. Market size and forecast, by Distribution Channel
      • 12.4.10.1.8. Market size and forecast, by End User
      • 12.4.10.2. China
      • 12.4.10.2.1. Market size and forecast, by Type
      • 12.4.10.2.2. Market size and forecast, by Base
      • 12.4.10.2.3. Market size and forecast, by Prescription Type
      • 12.4.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.2.6. Market size and forecast, by Age Group
      • 12.4.10.2.7. Market size and forecast, by Distribution Channel
      • 12.4.10.2.8. Market size and forecast, by End User
      • 12.4.10.3. India
      • 12.4.10.3.1. Market size and forecast, by Type
      • 12.4.10.3.2. Market size and forecast, by Base
      • 12.4.10.3.3. Market size and forecast, by Prescription Type
      • 12.4.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.3.6. Market size and forecast, by Age Group
      • 12.4.10.3.7. Market size and forecast, by Distribution Channel
      • 12.4.10.3.8. Market size and forecast, by End User
      • 12.4.10.4. Rest of Asia-Pacific
      • 12.4.10.4.1. Market size and forecast, by Type
      • 12.4.10.4.2. Market size and forecast, by Base
      • 12.4.10.4.3. Market size and forecast, by Prescription Type
      • 12.4.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.4.6. Market size and forecast, by Age Group
      • 12.4.10.4.7. Market size and forecast, by Distribution Channel
      • 12.4.10.4.8. Market size and forecast, by End User
  • 12.5. LAMEA
    • 12.5.1. Key market trends, growth factors and opportunities
    • 12.5.2. Market size and forecast, by Type
    • 12.5.3. Market size and forecast, by Base
    • 12.5.4. Market size and forecast, by Prescription Type
    • 12.5.5. Market size and forecast, by Therapeutic Application
    • 12.5.6. Market size and forecast, by Fill Volume Categories
    • 12.5.7. Market size and forecast, by Age Group
    • 12.5.8. Market size and forecast, by Distribution Channel
    • 12.5.9. Market size and forecast, by End User
    • 12.5.10. Market size and forecast, by country
      • 12.5.10.1. Latin America
      • 12.5.10.1.1. Market size and forecast, by Type
      • 12.5.10.1.2. Market size and forecast, by Base
      • 12.5.10.1.3. Market size and forecast, by Prescription Type
      • 12.5.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.1.6. Market size and forecast, by Age Group
      • 12.5.10.1.7. Market size and forecast, by Distribution Channel
      • 12.5.10.1.8. Market size and forecast, by End User
      • 12.5.10.2. Middle East And Africa
      • 12.5.10.2.1. Market size and forecast, by Type
      • 12.5.10.2.2. Market size and forecast, by Base
      • 12.5.10.2.3. Market size and forecast, by Prescription Type
      • 12.5.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.2.6. Market size and forecast, by Age Group
      • 12.5.10.2.7. Market size and forecast, by Distribution Channel
      • 12.5.10.2.8. Market size and forecast, by End User

CHAPTER 13: COMPETITIVE LANDSCAPE

  • 13.1. Introduction
  • 13.2. Top winning strategies
  • 13.3. Product mapping of top 10 player
  • 13.4. Competitive dashboard
  • 13.5. Competitive heatmap
  • 13.6. Top player positioning, 2023

CHAPTER 14: COMPANY PROFILES

  • 14.1. Intas Pharmaceuticals Ltd.
    • 14.1.1. Company overview
    • 14.1.2. Key executives
    • 14.1.3. Company snapshot
    • 14.1.4. Operating business segments
    • 14.1.5. Product portfolio
  • 14.2. Pfizer Inc.
    • 14.2.1. Company overview
    • 14.2.2. Key executives
    • 14.2.3. Company snapshot
    • 14.2.4. Operating business segments
    • 14.2.5. Product portfolio
    • 14.2.6. Business performance
  • 14.3. Church & Dwight Co. Inc.
    • 14.3.1. Company overview
    • 14.3.2. Key executives
    • 14.3.3. Company snapshot
    • 14.3.4. Operating business segments
    • 14.3.5. Product portfolio
    • 14.3.6. Business performance
  • 14.4. Zydus Lifesciences Limited
    • 14.4.1. Company overview
    • 14.4.2. Key executives
    • 14.4.3. Company snapshot
    • 14.4.4. Operating business segments
    • 14.4.5. Product portfolio
    • 14.4.6. Business performance
    • 14.4.7. Key strategic moves and developments
  • 14.5. Bayer AG
    • 14.5.1. Company overview
    • 14.5.2. Key executives
    • 14.5.3. Company snapshot
    • 14.5.4. Operating business segments
    • 14.5.5. Product portfolio
    • 14.5.6. Business performance
  • 14.6. Novartis AG
    • 14.6.1. Company overview
    • 14.6.2. Key executives
    • 14.6.3. Company snapshot
    • 14.6.4. Operating business segments
    • 14.6.5. Product portfolio
    • 14.6.6. Business performance
  • 14.7. Sanofi S.A.
    • 14.7.1. Company overview
    • 14.7.2. Key executives
    • 14.7.3. Company snapshot
    • 14.7.4. Operating business segments
    • 14.7.5. Product portfolio
    • 14.7.6. Business performance
  • 14.8. Bliss GVS Pharma Ltd
    • 14.8.1. Company overview
    • 14.8.2. Key executives
    • 14.8.3. Company snapshot
    • 14.8.4. Operating business segments
    • 14.8.5. Product portfolio
    • 14.8.6. Business performance
  • 14.9. Bausch Health Companies Inc.
    • 14.9.1. Company overview
    • 14.9.2. Key executives
    • 14.9.3. Company snapshot
    • 14.9.4. Operating business segments
    • 14.9.5. Product portfolio
    • 14.9.6. Business performance
  • 14.10. Cosette Pharmaceuticals, Inc.
    • 14.10.1. Company overview
    • 14.10.2. Key executives
    • 14.10.3. Company snapshot
    • 14.10.4. Operating business segments
    • 14.10.5. Product portfolio